1313757-53-7

Upstream product

• 119754-15-3 4-ethynyl-N-methylbenzenamine 
• 105-36-2 ethyl bromoacetate 
• 14235-81-5 4-Ethynylaniline 
• 1313757-66-2 N-((4-ethynyl)phenyl)glycine ethyl ester 
• 74-88-4 methyl iodide 

Downstream Products

• 1313757-59-3 C₂₆H₃₈N₄O₅ 
• 1313757-58-2 C₄₆H₆₄N₆O₈ 
• 1313757-60-6 C₅₂H₇₄N₈O₁₀ 
• 1313757-61-7 N(α)-[4-(1,1,4,4-tetracyanobuta-1,3-dien-2-yl)phenyl]-N(α)-(methyl)-glycyl-valine methyl ester 
• 1313757-62-8 C₂₉H₃₃N₇O₄ 
• 1313757-63-9 C₃₂H₃₈N₈O₅ 
• 1313757-64-0 C₄₀H₄₂N₈O₆ 
• 1313757-65-1 C₅₂H₆₄N₁₀O₈ 
• 1379188-93-8 C₁₁H₁₁NO₂ 
• 1313757-54-8 C₁₅H₁₄N₂O₄ 
• 1313757-55-9 N(α)-(4-ethynylphenyl)-N(α)-(methyl)-glycyl-valine methyl ester 
• 1313757-56-0 C₃₄H₄₂N₄O₆ 
• 1313757-57-1 C₂₃H₃₃N₃O₄ 

Relevant academic research and scientific papers

COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES

The invention relates to compounds of formula (II) for using in imaging and particularly for the diagnosis of neurodegenerative diseases

A convenient synthesis of new chromophoric tetracyanobutadiene-scaffolded peptides via a dipolar [2+2] cycloaddition-cycloreversion reaction

Herein, we report a novel approach for the synthesis of π-conjugated peptide-based donor-acceptor (D-π-A) chromophores, by reacting electron-rich alkynes with tetracyanoethylene. The desired tetracyanobutadiene-scaffolded peptides were obtained in good yields with various optical properties, λmax: 321-492 nm, ε: 21,000-65,000 mol-1 dm3 cm-1 depending on the substitution pattern of the cyanobutadiene scaffold.